Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications

Area of Science:

• Immunology
• Oncology
• Infectious Diseases

Background:

• Heat-shock proteins (HSPs) are ancient molecules involved in cellular stress responses.
• HSPs play a critical role in orchestrating immune responses.
• Extensive basic research has elucidated the mechanisms of HSPs in immunity.

Purpose of the Study:

• To review the history of basic research on HSPs and their role in immune response.
• To highlight the translation of HSP knowledge into clinical applications.
• To provide a rationale for the clinical use of HSP-based therapies.

Main Methods:

• Review of existing literature on heat-shock proteins (HSPs) and their immunological functions.
• Analysis of ongoing and completed clinical trials involving autologous HSP-peptide complexes.
• Examination of preclinical and clinical data for HSP-based treatments in cancer and infectious diseases.

Main Results:

• Over 150 global medical centers are conducting Phase III trials for HSP-peptide complexes in renal cell carcinoma and melanoma.
• HSP-peptide complexes are also under investigation in Phase I and II trials for leukemia, lymphoma, and various gastrointestinal cancers.
• Clinical trials for off-the-shelf HSP-based treatments for infectious diseases have recently commenced.

Conclusions:

• A deep understanding of HSPs' role in immune response to cancer and infections has been achieved.
• The clinical application of HSP-based therapies is supported by a strong scientific rationale.
• HSP-peptide complexes represent a promising therapeutic strategy for both oncological and infectious diseases.